
QuantaMatrix Incorporated — Investor Relations & Filings
QuantaMatrix Incorporated is an in-vitro diagnostics (IVD) company specializing in the development and manufacturing of medical devices using microbial diagnostics technology. The company focuses on providing rapid diagnostic solutions for critical conditions, with a primary emphasis on sepsis. Its flagship product, dRAST™ (direct & Rapid Antimicrobial Susceptibility Test), significantly reduces the time for determining effective antibiotics for sepsis patients, providing results in as few as four hours from a positive blood culture, compared to several days for conventional methods. This technology, which utilizes microfluidic channels and time-lapse microscopic imaging, enables faster, targeted antimicrobial therapy. In addition to sepsis, QuantaMatrix develops diagnostic solutions for other areas, including tuberculosis (QDST™), Alzheimer's disease (QPLEX™), and cardiovascular diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주식등의대량보유상황보고서(일반) | 2026-04-01 | Korean | |
| 정기주주총회결과 | 2026-03-31 | Korean | |
| 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-31 | Korean | |
| 사업보고서 (2025.12) | 2026-03-23 | Korean | |
| 감사보고서제출 | 2026-03-23 | Korean | |
| 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2026-03-16 | Korean |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 33135191 | 주식등의대량보유상황보고서(일반) | 2026-04-01 | Korean | ||
| 33095690 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33095685 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-31 | Korean | ||
| 33014647 | 사업보고서 (2025.12) | 2026-03-23 | Korean | ||
| 33011541 | 감사보고서제출 | 2026-03-23 | Korean | ||
| 32954457 | 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2026-03-16 | Korean | ||
| 32953384 | 주주총회소집결의 | 2026-03-16 | Korean | ||
| 32953371 | 주주총회소집공고 | 2026-03-16 | Korean | ||
| 32915527 | 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-03-09 | Korean | ||
| 32545537 | 타법인주식및출자증권취득결정 | 2026-02-20 | Korean | ||
| 32545532 | 유상증자결정(종속회사의주요경영사항) | 2026-02-20 | Korean | ||
| 13318999 | 주식등의대량보유상황보고서(일반) | 2026-01-26 | Korean | ||
| 13318874 | 주식등의대량보유상황보고서(일반) | 2026-01-26 | Korean | ||
| 12264289 | 주식등의대량보유상황보고서(약식) | 2026-01-08 | Korean | ||
|
2025
1 filing
| |||||
| 12197271 | 주식등의대량보유상황보고서(일반) | 2025-12-30 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Avidity Biosciences, Inc.
Develops a class of RNA therapeutics called Antibody Oligon…
|
RNA | US | Manufacturing |
|
Avivagen Inc.
Developed natural health products and feed additives; filed…
|
VIV | CA | Manufacturing |
|
Awakn Life Sciences Corp. (1169082 BC Ltd.)
Clinical-stage biotech developing novel therapeutics, inclu…
|
AWKN | CA | Manufacturing |
|
Axcan Pharma Inc.
Specialty pharmaceutical company focused on prescription th…
|
AXCA | CA | Manufacturing |
|
Axogen, Inc.
Develops and commercializes surgical solutions for peripher…
|
AXGN | US | Manufacturing |
|
Axsome Therapeutics, Inc.
A biopharmaceutical company developing therapies for centra…
|
AXSM | US | Manufacturing |
|
AYTU BIOPHARMA, INC
A specialty pharma company developing novel therapeutics fo…
|
AYTU | US | Manufacturing |
|
Ayurcann
Award-winning post-harvest cannabis solution provider offer…
|
AYUR | CA | Manufacturing |
|
Azitra, Inc.
Clinical-stage biopharma company developing microbiome-base…
|
AZTR | US | Manufacturing |
|
Bachem Holding AG
A CDMO developing and manufacturing peptides and oligonucle…
|
BANB | CH | Manufacturing |
QuantaMatrix Incorporated via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15060/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15060 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15060 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15060 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15060}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for QuantaMatrix Incorporated (id: 15060)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.